About 70,400 results
https://finance.yahoo.com/q?s=arnaView the basic ARNA stock chart on Yahoo Finance. ... Arena Pharmaceuticals
Inc (NASDAQ:ARNA): Is Healthcare Attractive Relative To NasdaqGS Peers?
Arena Pharmaceuticals Inc (NASDAQ:ARNA), a $1.47B small-cap, operates in
the healthcare industry, which has experienced tailwinds from issues such as
https://www.nasdaq.com/symbol/arnaCommon Stock Quote & Summary Data.
... Arena Pharmaceuticals (ARNA) Key Opinion Leader Event on S1P Modulation and Etrasimod in Autoimmune Diseases - Slideshow.
... Additionally, we have collaborations with the following pharmaceutical companies: Eisai Inc. and Eisai Co., Ltd ...
https://www.marketwatch.com/investing/stock/arnaDJIA F, 25,237, 3, 0.01%. S&P F, 2,736.25, 2.25, 0.08%. NASDAQ F, 6,781.50, -
34.50, -0.51%. Gold, 1,349.40, -5.90, -0.44%. Silver, 16.60, -0.196, -1.17%.
Crude Oil, 61.61, 0.27, 0.44% ...
... sector and description for Arena Pharmaceuticals. A clinical-stage
Rating: 2 - 836 votes
biopharmaceutical company focused on discovering, developing and
commercializing oral drugs in four major therapeutic areas: cardiovascular,
central nervous system, inflammatory and metabolic diseases. Exchange:
NASDAQ; Sector: Healthcare ...
https://stocktwits.com/symbol/ARNA2 days ago ... Arena Pharmaceuticals (Nasdaq: ARNA) CEO Amit Munshi discusses refining
Arena's strategy to focus on drug development emphasizing its strong product
pipeline. He details recent advances in Arena's two lead programs: Ralinepag
and Etrasimod, for the treatment of Pulmonary Arterial Hypertension ...
https://seekingalpha.com/.../4138487-arena-pharmaceuticals-significance- quarters-catalystsJan 18, 2018 ... Summary. Analysis of upcoming catalysts in this quarter. Reading between the
lines: some unexpected key events that may come to fruition this quarter. Arena
will grow to fair value once this quarter's events unfold. Arena Pharmaceuticals (
NASDAQ:ARNA) has had a tremendous run in the past few months.
https://seekingalpha.com/.../4137067-arena-pharmaceuticals-binary-events- horizonJan 11, 2018 ... Arena Pharmaceuticals (ARNA) is setting itself up for an interesting start to 2018.
The company presented at the 36th Annual JP Morgan Healthcare Conference
on January 10th and outlined its initiatives for the year which include some
compelling binary events. These types of events can provide a great ...
https://www.thestreet.com/quote/ARNA.htmlView detailed financial information, real-time news, videos, quotes and analysis
on Arena Pharmaceuticals Inc. (NASDAQ:ARNA). Explore commentary on Arena
Pharmaceuticals Inc. and hear what the experts at TheStreet are saying about
Are you considering Arena Pharmaceuticals (NASDAQ:ARNA) stock for your
Rating: 2.4 - 434 votes
investment portfolio? View ARNA's latest stock price, price target, analyst ratings,
earnings information, headlines, insider trades and SEC filings in real-time at
https://www.zacks.com/stock/quote/ARNAView Arena Pharmaceuticals, Inc. ARNA investment & stock information. Get the
latest Arena Pharmaceuticals, Inc. ARNA detailed stock quotes, stock data, Real-
Time ECN, charts, stats and more.
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. Wikipedia
Headquarters: San Diego, CA
CEO: Amit D. Munshi
CFO: Kevin R. Lind
Chief medical officer: Preston Klassen (M.h.s., Research, Development)